Patents by Inventor Ofir Moreno

Ofir Moreno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20230372287
    Abstract: Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions.
    Type: Application
    Filed: August 1, 2023
    Publication date: November 23, 2023
    Inventors: George JEOFFREYS, Alison JOHNSON, Andrew HEATON, Ofir MORENO
  • Isoflavonoid compositions and methods for the treatment of cancer
    Patent number: 11723893
    Abstract: Provided herein is a pharmaceutical composition comprising an isoflavonoid derivative and a cyclodextrin. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions. In specific instances, provided herein are intravenous compositions and therapies.
    Type: Grant
    Filed: March 5, 2021
    Date of Patent: August 15, 2023
    Assignee: MEI Pharma, Inc.
    Inventor: Ofir Moreno
  • ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20230145478
    Abstract: Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions.
    Type: Application
    Filed: January 13, 2023
    Publication date: May 11, 2023
    Inventors: George JEOFFREYS, Alison JOHNSON, Andrew HEATON, Ofir MORENO
  • Isoflavonoid compounds and methods for the treatment of cancer
    Patent number: 11583514
    Abstract: Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions.
    Type: Grant
    Filed: September 17, 2020
    Date of Patent: February 21, 2023
    Assignee: MEI Pharma, Inc.
    Inventors: George Jeoffreys, Alison Johnson, Andrew Heaton, Ofir Moreno
  • ISOFLAVONOID COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20210361614
    Abstract: Provided herein is a pharmaceutical composition comprising an isoflavonoid derivative and a cyclodextrin. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions. In specific instances, provided herein are intravenous compositions and therapies.
    Type: Application
    Filed: March 5, 2021
    Publication date: November 25, 2021
    Inventor: Ofir MORENO
  • Isoflavonoid compositions and methods for the treatment of cancer
    Patent number: 10973799
    Abstract: Provided herein is a pharmaceutical composition comprising an isoflavonoid derivative and a cyclodextrin. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions. In specific instances, provided herein are intravenous compositions and therapies.
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: April 13, 2021
    Assignee: MEI PHARMA, INC.
    Inventor: Ofir Moreno
  • ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20210000790
    Abstract: Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions.
    Type: Application
    Filed: September 17, 2020
    Publication date: January 7, 2021
    Inventors: George JEOFFREYS, Alison JOHNSON, Andrew HEATON, Ofir MORENO
  • ISOFLAVONOID COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20200121635
    Abstract: Provided herein is a pharmaceutical composition comprising an isoflavonoid derivative and a cyclodextrin. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions. In specific instances, provided herein are intravenous compositions and therapies.
    Type: Application
    Filed: June 18, 2019
    Publication date: April 23, 2020
    Inventor: Ofir MORENO
  • Isoflavonoid compositions and methods for the treatment of cancer
    Patent number: 10369132
    Abstract: Provided herein is a pharmaceutical composition comprising an isoflavonoid derivative and a cyclodextrin. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions. In specific instances, provided herein are intravenous compositions and therapies.
    Type: Grant
    Filed: April 24, 2018
    Date of Patent: August 6, 2019
    Assignee: MEI PHARMA, INC.
    Inventor: Ofir Moreno
  • ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20190142790
    Abstract: Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions.
    Type: Application
    Filed: September 12, 2018
    Publication date: May 16, 2019
    Inventors: George JEOFFREYS, Alison JOHNSON, Andrew HEATON, Ofir MORENO
  • Isoflavonoid compounds and methods for the treatment of cancer
    Patent number: 10105346
    Abstract: Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: October 23, 2018
    Assignee: MEI PHARMA, INC.
    Inventors: George Jeoffreys, Alison Johnson, Andrew Heaton, Ofir Moreno
  • ISOFLAVONOID COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20180237411
    Abstract: Provided herein is a pharmaceutical composition comprising an isoflavonoid derivative and a cyclodextrin. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions. In specific instances, provided herein are intravenous compositions and therapies.
    Type: Application
    Filed: April 24, 2018
    Publication date: August 23, 2018
    Inventor: Ofir MORENO
  • Isoflavonoid compositions and methods for the treatment of cancer
    Patent number: 9981936
    Abstract: Provided herein is a pharmaceutical composition comprising an isoflavonoid derivative and a cyclodextrin. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions. In specific instances, provided herein are intravenous compositions and therapies.
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: May 29, 2018
    Assignee: MEI Pharma, Inc.
    Inventor: Ofir Moreno
  • ISOFLAVONOID COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20170342044
    Abstract: Provided herein is a pharmaceutical composition comprising an isoflavonoid derivative and a cyclodextrin. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions. In specific instances, provided herein are intravenous compositions and therapies.
    Type: Application
    Filed: June 14, 2017
    Publication date: November 30, 2017
    Inventor: Ofir MORENO
  • ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20170246142
    Abstract: Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions.
    Type: Application
    Filed: March 10, 2017
    Publication date: August 31, 2017
    Inventors: George JEOFFREYS, Alison JOHNSON, Andrew HEATON, Ofir MORENO
  • Isoflavonoid compositions and methods for the treatment of cancer
    Patent number: 9708283
    Abstract: Provided herein is a pharmaceutical composition comprising an isoflavonoid derivative and a cyclodextrin. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions. In specific instances, provided herein are intravenous compositions and therapies.
    Type: Grant
    Filed: November 1, 2011
    Date of Patent: July 18, 2017
    Assignee: MEI PHARMA, INC.
    Inventor: Ofir Moreno
  • Isoflavonoid compounds and methods for the treatment of cancer
    Patent number: 9663484
    Abstract: Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions.
    Type: Grant
    Filed: November 1, 2011
    Date of Patent: May 30, 2017
    Assignee: MEI PHARMA, INC.
    Inventors: George Jeoffreys, Alison Johnson, Andrew Heaton, Ofir Moreno
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION
    Publication number: 20150266810
    Abstract: Provided are small-molecule Trp-p8 modulators, including Trp-p8 agonists and Trp-p8 antagonists, and compositions comprising small-molecule Trp-p8 agonists as well as methods for identifying and characterizing novel small-molecule Tip-p8 modulators and methods for decreasing viability and/or inhibiting growth of Trp-p8 expressing cells, methods for activating Trp-p8-mediated cation influx, methods for stimulating apoptosis and/or necrosis, and related methods for the treatment of diseases, including cancers such as lung, breast, colon, and/or prostate cancers as well as other diseases, such as benign prostatic hyperplasia, that are associated with Tip-p8 expression.
    Type: Application
    Filed: January 23, 2015
    Publication date: September 24, 2015
    Inventors: Sateesh Natarajan, Ofir Moreno, Thomas J. Graddis, David F. Duncan, Reiner Laus, Feng Chen
  • ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20140234295
    Abstract: Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions.
    Type: Application
    Filed: November 1, 2011
    Publication date: August 21, 2014
    Applicant: MARSHALL EDWARDS, INC.
    Inventors: George Jeoffreys, Alison Johnson, Andrew Heaton, Ofir Moreno
  • Small-molecule modulators of Trp-p8 activity
    Patent number: 8618155
    Abstract: Provided are small-molecule Trp-p8 modulators, including Trp-p8 agonists and Trp-p8 antagonists, and compositions comprising small-molecule Trp-p8 agonists as well as methods for identifying and characterizing novel small-molecule Trp-p8 modulators and methods for decreasing viability and/or inhibiting growth of Trp-p8 expressing cells, methods for activating Trp-p8-mediated cation influx, methods for stimulating apoptosis and/or necrosis, and related methods for the treatment of diseases, including cancers such as lung, breast, colon, and/or prostate cancers as well as other diseases, such as benign prostatic hyperplasia, that are associated with Trp-p8 expression.
    Type: Grant
    Filed: August 9, 2010
    Date of Patent: December 31, 2013
    Assignee: Dendreon Corporation
    Inventors: Ofir Moreno, Sateesh Natarajan, David F. Duncan